Breen Edward D's Form 4 filing
DuPont de Nemours, Inc.DD · filed Nov 9, 2026
- Accession no.
- 0001628280-26-072339
- Filed
- Nov 9, 2026, 5:21 PM ET
- Trade date
- Aug 28-Nov 5, 2026
- Filing delay
- 73 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $13.2M. It was filed 73 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Breen Edward DCIK 0001223619 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 28, 2026 | Common Stock | GGiftAcquired | +35,551 | $0.00 | $0 | 127,275.5715 | Direct | |
| Nov 5, 2026 | Common Stock | MOption exerciseAcquired | +89,845 | $108.84 | +$9,778,729.8 | 217,120.5715 | Direct | |
| Nov 5, 2026 | Common Stock | SSaleDisposed | −89,845 | $146.41F3 | −$13,154,206.45 | 127,275.5715 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 5, 2026 | Common Stock | MOption exerciseAcquired | +89,845 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
Weighted average sales price of $146.4176. Trades ranged from $144.04 to $149.28. Upon request, the reporting person will provide to the Commission, the issuer and any stockholder full information regarding the number of shares that were sold at each separate price.
Referenced by the price of 1 transaction in Table I.